A phase II trial of FUdR in patients with advanced pancreatic cancer Bach ArdalanMayra Lima Original Paper 29 July 2004 Pages: 561 - 566
Effects of the angiotensin-I converting enzyme inhibitor perindopril on tumor growth and angiogenesis in head and neck squamous cell carcinoma cells Ryuji YasumatsuTorahiko NakashimaShizuo Komune Original Paper 27 July 2004 Pages: 567 - 573
Methylenetetrahydrofolate reductase C677T polymorphism and predisposition towards esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population Jianhui ZhangRainer B. ZotzMario Sarbia Original Paper 29 July 2004 Pages: 574 - 580
Quality of adjuvant CMF chemotherapy for node-positive primary breast cancer: a population-based study Michael SchaapveldElisabeth G. E. de VriesPax H. B. Willemse Original Paper 16 July 2004 Pages: 581 - 590
Potent antitumoral efficacy of a novel replicative adenovirus CNHK300 targeting telomerase-positive cancer cells C.-Q. SuJ. ShamQ.-J. Qian Original Paper 09 July 2004 Pages: 591 - 603
Gefitinib (‘IRESSA’, ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation Lorella BonaccorsiSara MarchianiElisabetta Baldi Original Paper 16 July 2004 Pages: 604 - 614
Differential proteomic analysis of human hepatocellular carcinoma cell line metastasis-associated proteins Jie-Feng CuiYin-Kun LiuPeng-Yuan Yang Original Paper 09 July 2004 Pages: 615 - 622
Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration Evangelos TerposMarianna PolitouAmin Rahemtulla Rapid Communication 28 July 2004 Pages: 623 - 625